Genentech

Genentech, Inc. (), is the acronym of Genetic Engineering Technology, Inc. . The company is an international leader in the field of the Biotechnologie. The company was founded in 1976 by Robert A. Swanson, a young investor, and the biochemist D Herbert W. Boyer. The foundation of the company is recognized like the creation of biotechnological industry.

D Herbert W. Boyer was recognized universally for its work based on DNA recombining. With his/her colleague of the time, D Cohen, they made the invention of a technique which allows the transfer of genes of an organization another. With the assistance of this invention, it is from now on possible to produce recombining proteins with large scales. Today, this technique of cloning is combined with other techniques developped at the point by Genentech in order to produce drugs of high technology very.

In 2007, Genentech employs more than 10.000 people. The company is a subsidiary company of the Swiss pharmaceutical group Hoffmann it Rock. .

Product Timeline

1982 - human Insulin - First biological product of order approved in the world (sold in Eli Lilly)
1985 - Protropin ® (somatrem) - Growth hormone for child with hormonal deficiency.
1987 - Activase ® (activator of “recombining tissue plasminogen”) - Dissolves the cayeaux blood ones among patients reached of myocardial infarction. Draft also the non-hemoragic heart attack.
1990 - Actimmune ® (interferon gamma 1b) - molecule sold with Intermune).
1993 - Nutropin ® (recombining somatropin) - Growth hormone for children and adults before renal transplatation
1994 - Pulmozyme ® (dornase esparto) - DNA recombining for the treatment of the cystic fibrosis.
1997 - Rituxan ® (rituximab) - Treatment for specific type of lymphomas (cancer).
1998 - Herceptin ® (trastuzumab) - Treatment of breast cancer among patients (be) whose gene HER2 is implied.
2000 - TNKase ® (tenecteplase) - " Closes-busting " treatment of the myocardial infarction.
2003 - Xolair ® (omalizumab) - Treatment of asthma.
2003 - Raptiva ® (efalizumab) - Antibody which decontaminates the cells T and eliminates the development from psoriasis.
2004 - Avastin ® (bevacizumab) - Anti-VEGF monoclonal Antibody for the treatment of the cancer of the colonist and the rectum.
2004 - Tarceva ® (erlotinib) - Treatment against lung cancer and of the pancreas.
2006 - Lucentis ® (ranibizumab injection) - Drug approved by “The U.S. Food and Drug Administration (FDA)” for the treatment of the degeneration of the retina.

Outstanding facts

Fortune named Genentech the best place to work in the United States (2006). In 2007, the company was named second, after Google.

Sites

The principal campus of Genentech is located at South San Francisco in California. This campus is directly located on bank of the Baie of San Francisco is account more than 30 buildings. Genentech has also production centres with Vacaville (California) and Oceanside (California). Moreover, new production centres are in construction with Hillsboro (Oregon) and with Singapore.

References

External bonds

Official site
Human Growth Hormone Glossary
has Cancer Drug Shows Promised, At has Price That Many Can' T Pay NewYork Times , February 15,2006, Alex Berenson
Presentation by Genentech employed butt Sustainable Business Jan 10th, 2007
Genentech stock quote & chart

Random links: